Deleted Tweets From Scott Gottlieb, R-D.C.

This isn’t speculation. Studies show e-cig vapor contains chemicals that can damage cells, and cause illness. Research shows substances found in e-cigs vapor can pose a risk for decreased lung development, breathing difficulties, and vaping induced inflammatory reactions.

And we know this exposure is a major health concern due to the ability of e-cig particles to penetrate deep into respiratory system. Some of the toxic chemicals and other substances contained in e-cigs can go deep into the lungs and may pose risk for diseases not seen in smokers

Four distinct types of ENDS products are being tested, each with three different flavors. We need to fully evaluate potential risks that we’ve identified – to inform the public as well as our own regulatory decision-making.

We’re especially concerned by evidence from animal studies that the vapor in e-cigs can cause changes to tissue in the airways that can induce cancer or be a precursor to cancer.

Today, I’m announcing FDA has initiated a comprehensive research plan to fully evaluate these risks and we’ll report our results publicly. The FDA’s Center for Tobacco Products and Center for Drug Evaluation and Research are already leading the efforts.

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA on steps toward a new, tailored review framework for artificial intelligence-based medical devices https://t.co/PBg5fFDlkt

RT @Health_Affairs: New on @Health_Affairs blog: "Rx Drug Policy At The @US_FDA: Looking Back At @SGottliebFDA And Ahead To Sharpless by @RESachs https://t.co/5GpMtiQxG1

RT @US_FDA: FDA’s Centers for Tobacco @FDATobacco and Drugs @FDA_Drug_Info have begun comprehensive research and toxicity studies to evaluate the risks posed by e-cigarettes to better inform and protect the public.

RT @US_FDA: Cigarette smoke is dangerous not just because of the toxic chemicals it’s loaded with, but also how the chemicals and particles enter the body and cause damage to it. #FDAVoices explains https://t.co/fLMvUXh9SI https://t.co/tnNiSxXXRb

RT @US_FDA: Aerosol produced by some e-cigarettes can contain high amounts of some toxic substances, which can pose a risk to the lungs, lower the body’s defense again pathogens and mimic metastatic cancer.

RT @BioCentury: In his last hearing as commissioner, @SGottliebFDA suggests moratorium on human germline gene editing research. He says it imperils less controversial gene editing applications. https://t.co/UyqhQnMjZM

RT @maggiemfox: More @US_FDA warnings to bogus stem cell clinics https://t.co/4sUQrfkQZQ

You can read about our efforts on our draft MOU with states and our work on hospital or health system compounding in our statement: https://t.co/s4rpviAjEz The quality of compounded drugs for patients who need them is a priority and we’ll continue to work to refine our practices https://t.co/bRxBiMf0wv

RT @RebeccaDRobbins: The FDA just said that it has received 35 reports of people suffering seizures after vaping between 2010 and 2019, ⁦@meggophone⁩ reports https://t.co/fqp0CrttLG

THREAD: Today, we’re sharing our 2019 compounding priorities as we work to ensure continued access to compounded drugs for patients who need them while also protecting patients from the risks of contaminated or otherwise harmful products. https://t.co/s4rpviAjEz https://t.co/bGipK4kWq8

We’ve seen poor conditions at compounding facilities, and we’ll be working to promote activities to help identify and correct insanitary conditions. We’ll also continue to consider substances nominated for inclusion on the bulks lists and the supporting research in this area.

RT @DrAbernethyFDA: Good morning! I'm "FDA Official" on Twitter now. Follow me here to learn more about the important work we do at @US_FDA!

Today, #FDA announced it’s making available the adverse event reports related to medical products used in animals on @openFDA. This action is part of a broader effort to increase the transparency and sharing of adverse event report data. https://t.co/cz0WZ9uNSj

The availability of this data on @openFDA follows other agency efforts related to ensuring public access to safety-related information. For more info and to check out @openFDA, visit: https://t.co/12IeDlPurY https://t.co/K9pClTsXZV

RT @FDAfood: FDA will hold a public meeting � to discuss the draft guidance to protect food against intentional adulteration. At… https://t.co/1ckjmEi9SO

This isn’t speculation. Studies show e-cig vapor contains chemicals that can damage cells, and cause illness. Research shows substances found in e-cigs vapor can pose a risk for decreased lung development, breathing difficulties, and vaping induced inflammatory reactions.

And we know this exposure is a major health concern due to the ability of e-cig particles to penetrate deep into respiratory system. Some of the toxic chemicals and other substances contained in e-cigs can go deep into the lungs and may pose risk for diseases not seen in smokers

Four distinct types of ENDS products are being tested, each with three different flavors. We need to fully evaluate potential risks that we’ve identified – to inform the public as well as our own regulatory decision-making.

We’re especially concerned by evidence from animal studies that the vapor in e-cigs can cause changes to tissue in the airways that can induce cancer or be a precursor to cancer.

Today, I’m announcing FDA has initiated a comprehensive research plan to fully evaluate these risks and we’ll report our results publicly. The FDA’s Center for Tobacco Products and Center for Drug Evaluation and Research are already leading the efforts.

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA on steps toward a new, tailored review framework for artificial intelligence-based medical devices https://t.co/PBg5fFDlkt

RT @Health_Affairs: New on @Health_Affairs blog: "Rx Drug Policy At The @US_FDA: Looking Back At @SGottliebFDA And Ahead To Sharpless by @RESachs https://t.co/5GpMtiQxG1

RT @US_FDA: FDA’s Centers for Tobacco @FDATobacco and Drugs @FDA_Drug_Info have begun comprehensive research and toxicity studies to evaluate the risks posed by e-cigarettes to better inform and protect the public.

RT @US_FDA: Cigarette smoke is dangerous not just because of the toxic chemicals it’s loaded with, but also how the chemicals and particles enter the body and cause damage to it. #FDAVoices explains https://t.co/fLMvUXh9SI https://t.co/tnNiSxXXRb

RT @US_FDA: Aerosol produced by some e-cigarettes can contain high amounts of some toxic substances, which can pose a risk to the lungs, lower the body’s defense again pathogens and mimic metastatic cancer.

RT @BioCentury: In his last hearing as commissioner, @SGottliebFDA suggests moratorium on human germline gene editing research. He says it imperils less controversial gene editing applications. https://t.co/UyqhQnMjZM

RT @maggiemfox: More @US_FDA warnings to bogus stem cell clinics https://t.co/4sUQrfkQZQ

You can read about our efforts on our draft MOU with states and our work on hospital or health system compounding in our statement: https://t.co/s4rpviAjEz The quality of compounded drugs for patients who need them is a priority and we’ll continue to work to refine our practices https://t.co/bRxBiMf0wv

RT @RebeccaDRobbins: The FDA just said that it has received 35 reports of people suffering seizures after vaping between 2010 and 2019, ⁦@meggophone⁩ reports https://t.co/fqp0CrttLG

THREAD: Today, we’re sharing our 2019 compounding priorities as we work to ensure continued access to compounded drugs for patients who need them while also protecting patients from the risks of contaminated or otherwise harmful products. https://t.co/s4rpviAjEz https://t.co/bGipK4kWq8

We’ve seen poor conditions at compounding facilities, and we’ll be working to promote activities to help identify and correct insanitary conditions. We’ll also continue to consider substances nominated for inclusion on the bulks lists and the supporting research in this area.

RT @DrAbernethyFDA: Good morning! I'm "FDA Official" on Twitter now. Follow me here to learn more about the important work we do at @US_FDA!

Today, #FDA announced it’s making available the adverse event reports related to medical products used in animals on @openFDA. This action is part of a broader effort to increase the transparency and sharing of adverse event report data. https://t.co/cz0WZ9uNSj

The availability of this data on @openFDA follows other agency efforts related to ensuring public access to safety-related information. For more info and to check out @openFDA, visit: https://t.co/12IeDlPurY https://t.co/K9pClTsXZV

RT @FDAfood: FDA will hold a public meeting � to discuss the draft guidance to protect food against intentional adulteration. At… https://t.co/1ckjmEi9SO